Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Nov 27, 2026; 18(11): 125467
Published online Nov 27, 2026. doi: 10.4254/wjh.125467
Published online Nov 27, 2026. doi: 10.4254/wjh.125467
Non-cancer mortality in hepatocellular carcinoma: Population-based competing-risk study
Yi Yang, Lian-Lu Jiang, Department of Hepatobiliary, Pancreatic and Splenic Surgery, First Affiliated Hospital of Hunan College of TCM, Zhuzhou 412000, Hunan Province, China
Feng Liu, Xiao-Dong Chen, Department of General Surgery, The People’s Hospital of Wuchuan, Zunyi 564300, Guizhou Province, China
Author contributions: Yang Y made substantial intellectual contributions to the critical revision and finalization of the manuscript; Liu F contributed to the conceptualization of the study, formal analysis, methodology, software, visualization, and wrote the original draft; Yang Y, Liu F, and Chen XD performed data curation; Yang Y and Chen XD conducted investigation and validation; Yang Y, Liu F, Chen XD, and Jiang LL were responsible for writing, reviewing and editing the manuscript; Jiang LL contributed to the conceptualization of the study, methodology, project administration and supervision; and all authors reviewed and approved the final manuscript.
AI contribution statement: No artificial intelligence or AI-assisted technologies were used in this study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Lian-Lu Jiang, MM, Attending Physician, Department of Hepatobiliary, Pancreatic and Splenic Surgery, First Affiliated Hospital of Hunan College of TCM, No. 571 Renmin Middle Road, Zhuzhou 412000, Hunan Province, China. jiexiu666@gmail.com
Received: July 8, 2026
Revised: August 5, 2026
Accepted: October 8, 2026
Published online: November 27, 2026
Processing time: 134 Days and 8.9 Hours
Revised: August 5, 2026
Accepted: October 8, 2026
Published online: November 27, 2026
Processing time: 134 Days and 8.9 Hours
Core Tip
Core Tip: Among 31274 patients with hepatocellular carcinoma (HCC), 3880 non-HCC deaths represented 14.8% of all deaths. The proportional subdistribution hazards assumption was strongly violated; therefore, adjusted subdistribution hazard ratios were estimated at 12 months, 36 months, and 60 months rather than summarized by one constant value. Older age remained associated with higher non-HCC mortality, whereas apparent associations for tumor burden and treatment reflected competing HCC death, patient selection, and changing risk sets. These registry associations should not be read as causal treatment effects.